Among cancer patients with multidrug resistance or advanced metastatic solid tumors, Mn2+ rescues the clinical efficiency of some cancer treatments such as PD-1/PD-L1 therapy and greatly improves their prognosis [51, 54] (Fig. 2). Here, CD274 is linked to cancer.